Literature DB >> 16256316

Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L).

Kwang Hun Lim1, Tuan N Nguyen, Steven M Damo, Tanya Mazur, Haydn L Ball, Stanley B Prusiner, Alexander Pines, David E Wemmer.   

Abstract

The peptide fragment 89-143 of the prion protein (carrying a P101L mutation) is biologically active in transgenic mice when in a fibrillar form. Injection of these fibrils into transgenic mice (expressing full length PrP with the P101L mutation) induces a neurodegenerative prion disease (Kaneko et al., J. Mol. Biol. 295 (2000) 997). Here we present solid-state NMR studies of PrP(89-143)(P101L) fibrils, probing the conformation of residues in the hydrophobic segment 112-124 with chemical shifts. The conformations of glycine residues were analyzed using doubly (13)C=O labeled peptides by two-dimensional (2D) double-quantum correlation, and double-quantum filtered dephasing distance measurements. MQ-NMR experiments were carried out to probe the relative alignment of the individual peptides fibrils. These NMR studies indicate that the 112-124 segment adopts an extended beta-sheet conformation, though not in a parallel, in register alignment. There is evidence for conformational variability at Gly 113. DQ correlation experiments provide useful information in regions with conformational heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256316     DOI: 10.1016/j.ssnmr.2005.09.017

Source DB:  PubMed          Journal:  Solid State Nucl Magn Reson        ISSN: 0926-2040            Impact factor:   2.293


  16 in total

1.  The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.

Authors:  Robert Tycko; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  Probing the conformation of a prion protein fibril with hydrogen exchange.

Authors:  Steven M Damo; Aaron H Phillips; Anisa L Young; Sheng Li; Virgil L Woods; David E Wemmer
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

3.  Heterologous stacking of prion protein peptides reveals structural details of fibrils and facilitates complete inhibition of fibril growth.

Authors:  Ronald S Boshuizen; Veronica Schulz; Michela Morbin; Giulia Mazzoleni; Rob H Meloen; Johannes P M Langedijk
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

4.  Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils.

Authors:  Jonathan J Helmus; Krystyna Surewicz; Philippe S Nadaud; Witold K Surewicz; Christopher P Jaroniec
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

5.  Structural studies of truncated forms of the prion protein PrP.

Authors:  William Wan; Holger Wille; Jan Stöhr; Amy Kendall; Wen Bian; Michele McDonald; Sarah Tiggelaar; Joel C Watts; Stanley B Prusiner; Gerald Stubbs
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

6.  Protein-solvent interfaces in human Y145Stop prion protein amyloid fibrils probed by paramagnetic solid-state NMR spectroscopy.

Authors:  Darryl Aucoin; Yongjie Xia; Theint Theint; Philippe S Nadaud; Krystyna Surewicz; Witold K Surewicz; Christopher P Jaroniec
Journal:  J Struct Biol       Date:  2018-04-18       Impact factor: 2.867

Review 7.  Solid-state NMR studies of amyloid fibril structure.

Authors:  Robert Tycko
Journal:  Annu Rev Phys Chem       Date:  2011       Impact factor: 12.703

8.  Models of membrane-bound Alzheimer's Abeta peptide assemblies.

Authors:  Yinon Shafrir; Stewart Durell; Nelson Arispe; H Robert Guy
Journal:  Proteins       Date:  2010-10-11

Review 9.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Molecular polymorphism of Abeta in Alzheimer's disease.

Authors:  Harry Levine; Lary C Walker
Journal:  Neurobiol Aging       Date:  2008-07-10       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.